DBV Technologies SA Sponsored ADR Stock
DBV Technologies SA Sponsored ADR Stock price
Key metrics
| Market capitalization | $56.74m |
| Enterprise Value | $25.29m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 1.05 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-117.17m |
| Free Cash Flow (TTM) Free Cash Flow | $-108.72m |
| Cash position | $46.44m |
Is DBV Technologies SA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
DBV Technologies SA Sponsored ADR Stock Analysis
Analyst Opinions
4 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:
Analyst Opinions
4 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:
Financial data from DBV Technologies SA Sponsored ADR
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | 1.85 1.85 |
110%
110%
|
|
| EBITDA | -119 -119 |
32%
32%
|
EBIT (Operating Income) EBIT | -117 -117 |
9%
9%
|
| Net Profit | -102 -102 |
1%
1%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about DBV Technologies SA Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DBV Technologies SA Sponsored ADR Stock News
Company Profile
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. It focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
| Head office | France |
| CEO | Daniel Tassé |
| Employees | 104 |
| Founded | 2002 |
| Website | www.dbv-technologies.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
